STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

March 21, 2027

Study Completion Date

August 21, 2027

Conditions
Crohn DiseaseCalprotectinMRI
Interventions
RADIATION

MRI

2 additional MRI will be done for the CALM + MRI group

Trial Locations (17)

Unknown

NOT_YET_RECRUITING

Amiens university hospital, Amiens

NOT_YET_RECRUITING

Aurillac Hospital, Aurillac

NOT_YET_RECRUITING

Bayonne hospital, Bayonne

NOT_YET_RECRUITING

Bordeaux university hospital, Bordeaux

NOT_YET_RECRUITING

Chambery Hospital, Chambéry

RECRUITING

Clermont-Ferrand University hospital, Clermont-Ferrand

NOT_YET_RECRUITING

Grenoble University Hospital, Grenoble

NOT_YET_RECRUITING

Issoire Hospital, Issoire

NOT_YET_RECRUITING

LILLE university hospital, Lille

NOT_YET_RECRUITING

Lyon Hospital, Hospices civils de Lyon, Lyon

NOT_YET_RECRUITING

Montluçon Hospital, Montluçon

NOT_YET_RECRUITING

Montpellier University hospital, Montpellier

NOT_YET_RECRUITING

Nancy University hospital, Nancy

NOT_YET_RECRUITING

Nice University hospital, Nice

NOT_YET_RECRUITING

Rennes University Hospital, Rennes

NOT_YET_RECRUITING

Saint Etienne University Hospital, Saint-Etienne

NOT_YET_RECRUITING

Thiers Hospital, Thiers

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER